V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216588 | 20082508 | null | null | null | 2021-03-23 | 2021-04-13 | Capecitabine (14 day) + Irinotecan | 99 | null | CAPECITABINE + IRINOTECAN | 101753902 |
| 20216589 | 20082509 | 1.58 | 53.9 | Palliative (P) | null | 2017-12-01 | null | null | N | HCX | 101552512 |
| 20216590 | 20082510 | null | null | null | 2018-03-15 | 2018-03-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101460233 |
| 20216591 | 20082511 | null | 54.2 | Palliative (P) | null | 2018-12-14 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100439530 |
| 20216592 | 20082512 | 1.78 | 86 | Palliative (P) | 2019-01-17 | 2019-01-17 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101870147 |
| 20216593 | 20082513 | 1.83 | 54.7 | Palliative (P) | 2018-02-04 | 2018-02-22 | CAPECITABINE + MITOMYCIN + RT | null | N | CETUXIMAB + IRINOTECAN + MDG | 100130194 |
| 20216595 | 20082515 | 0 | 74 | Palliative (P) | 2017-03-08 | 2017-03-10 | LENVATINIB | 02 | N | LENVATINIB | 101645541 |
| 20216596 | 20082516 | 1.62 | 52 | Neo-adjuvant (N) | 2018-07-29 | 2018-08-10 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100202416 |
| 20216597 | 20082517 | 1.52 | 55.8 | Adjuvant (A) | null | 2018-01-23 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100464362 |
| 20216598 | 20082518 | 1.7 | 50 | Palliative (P) | null | 2016-12-06 | null | null | N | CISPLATIN + ETOPOSIDE | 100329184 |
| 20216599 | 20082519 | 1.7 | 55.4 | Neo-adjuvant (N) | null | 2018-04-25 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101651569 |
| 20216600 | 20082520 | null | null | null | null | 2019-10-06 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100437111 |
| 20216603 | 20082522 | 1.75 | 45.6 | Palliative (P) | null | 2018-09-08 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100070167 |
| 20216605 | 20082523 | 1.7 | 84.5 | Palliative (P) | 2019-01-09 | 2019-01-16 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101299093 |
| 20216610 | 20082526 | 1.73 | 107.5 | Palliative (P) | 2018-12-04 | 2018-12-08 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + IRINOTECAN | 101439228 |
| 20216611 | 20082527 | null | null | null | 2018-12-30 | 2019-01-12 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100413945 |
| 20216612 | 20082528 | null | null | null | 2017-03-02 | 2017-03-02 | ECarboX | 02 | null | CAPECITABINE + IRINOTECAN | 101785165 |
| 20216613 | 20082529 | null | null | null | 2016-08-03 | 2016-08-04 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101035224 |
| 20216614 | 20082530 | 1.86 | 69.3 | null | 2018-09-06 | 2018-09-08 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101871372 |
| 20216616 | 20082532 | 1.83 | 69.2 | Palliative (P) | 2019-06-30 | 2019-06-30 | null | null | N | HCX | 100609299 |
| 20216618 | 20082534 | null | null | null | null | 2019-09-15 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100292925 |
| 20216619 | 20082535 | 1.49 | 44.96 | Neo-adjuvant (N) | 2019-01-22 | 2019-02-02 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101868040 |
| 20216621 | 20082536 | 1.79 | null | Neo-adjuvant (N) | null | 2017-04-30 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101826216 |
| 20216622 | 20082537 | 1.49 | 70.6 | Neo-adjuvant (N) | 2017-09-21 | 2017-10-05 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100486874 |
| 20216625 | 20082540 | 1.79 | 48.9 | Curative (C) | 2019-08-22 | 2019-08-22 | HCX | N | null | HCX | 101864996 |
| 20216626 | 20082541 | null | null | null | 2016-09-27 | 2016-10-07 | Capecitabine (21 day) + Irinotecan | Y | null | CAPECITABINE + IRINOTECAN | 101643559 |
| 20216627 | 20082542 | 1.78 | 88.5 | Palliative (P) | 2019-03-27 | 2019-03-27 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100079983 |
| 20216628 | 20082543 | null | null | null | 2018-04-16 | 2018-04-29 | LENVATINIB | 02 | null | LENVATINIB | 101624330 |
| 20216629 | 20082544 | 1.74 | 50.9 | Curative (C) | null | 2018-01-15 | null | null | N | CISPLATIN + ETOPOSIDE | 100696176 |
| 20216630 | 20082545 | null | 84.15 | null | 2021-01-30 | 2021-01-30 | ECarboX | 02 | null | HCX | 100912207 |
| 20216631 | 20082546 | 1.69 | 86.5 | Adjuvant (A) | 2018-03-03 | 2018-06-03 | null | null | N | CISPLATIN + ETOPOSIDE | 100971015 |
| 20216632 | 20082547 | 1.57 | 80.2 | Palliative (P) | 2018-06-15 | 2018-06-22 | ECarboX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100216816 |
| 20216636 | 20082549 | 1.67 | 49.8 | Palliative (P) | 2019-03-23 | 2019-04-02 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101314624 |
| 20216637 | 20082550 | 1.7 | 71.8 | Palliative (P) | null | 2019-10-13 | null | null | N | HCX | 100317685 |
| 20216639 | 20082551 | 1.56 | null | Palliative (P) | null | 2017-01-09 | null | null | N | HCX | 100282421 |
| 20216640 | 20082552 | 1.59 | 93 | Palliative (P) | 2017-04-27 | 2017-04-29 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101216275 |
| 20216641 | 20082553 | 1.86 | null | Palliative (P) | null | 2017-12-29 | null | null | N | CISPLATIN + ETOPOSIDE | 101537855 |
| 20216643 | 20082554 | 1.73 | 58.7 | Curative (C) | 2016-07-19 | 2016-08-01 | null | null | N | CISPLATIN + ETOPOSIDE | 100392477 |
| 20216644 | 20082555 | null | null | null | 2019-08-12 | 2019-08-20 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101214760 |
| 20216646 | 20082557 | null | null | null | 2016-09-11 | 2016-09-11 | null | null | null | CISPLATIN + ETOPOSIDE | 101173842 |
| 20216647 | 20082558 | 1.69 | 131.6 | Palliative (P) | null | 2018-07-10 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100903122 |
| 20216648 | 20082559 | 1.68 | 84 | null | null | 2017-02-13 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100134684 |
| 20216649 | 20082560 | 1.87 | 76.9 | Palliative (P) | null | 2021-03-10 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100040285 |
| 20216650 | 20082561 | 1.85 | 95.1 | Palliative (P) | 2019-05-27 | 2019-06-03 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 100270371 |
| 20216651 | 20082562 | 1.74 | 106.7 | Curative (C) | 2017-07-10 | 2017-07-14 | CAPECITABINE + MITOMYCIN + RT | 02 | Y | CAPECITABINE + MITOMYCIN + RT | 101117388 |
| 20216652 | 20082563 | 1.64 | 78 | Palliative (P) | 2017-09-06 | 2017-09-15 | Cisplatin + Etoposide po | 02 | N | CISPLATIN + ETOPOSIDE | 100995181 |
| 20216653 | 20082564 | 1.71 | 63 | Adjuvant (A) | null | 2016-09-20 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100723403 |
| 20216655 | 20082566 | 1.73 | 68 | Palliative (P) | 2020-05-11 | 2020-05-12 | null | null | null | CISPLATIN + ETOPOSIDE | 100303594 |
| 20216658 | 20082567 | 1.64 | 86.2 | Palliative (P) | null | 2017-03-16 | null | null | N | LENVATINIB | 101490011 |
| 20216660 | 20082569 | null | null | null | null | 2020-08-08 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100009231 |